Time-Dependent Neuroendocrine Alterations and Drug Craving during the First Month of Abstinence in Heroin Addicts
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
RATIONALE: Heroin use and withdrawal cause abnormality in the endocrine system. However, the time course of neuroendocrine alterations in heroin addicts during pharmacologically unassisted withdrawal is still unclear. OBJECTIVES: To investigate alterations in cortisol, adrenocorticotrophic hormone (ACTH), beta-endorphin (beta-EP), leptin, and neuropeptide Y (NPY) during the first month of abstinence in heroin addicts. METHODS: Twelve heroin addicts and eight matched healthy control subjects were recruited for this study. The neuroendocrine alterations and self-reported heroin craving, anxiety, and depression in heroin addicts were assessed at different time points (days 3, 10, and 30) of first month of abstinence from heroin use. RESULTS: Self-reported heroin craving, anxiety, and depression in heroin addicts decreased gradually during the first month of abstinence. The cortisol levels increased from abstinence day 3 to 30, while ACTH and beta-EP levels decreased over this period in heroin addicts. The leptin and NPY levels were significantly decreased on days 3 and 10 but had normalized on day 30 of abstinence. A positive correlation between cortisol level and heroin craving, anxiety, and depression was observed, while a negative correlation was observed between beta-EP level and craving and anxiety and between leptin and depression and NPY and anxiety. CONCLUSIONS: Abnormal alterations in the neuroendocrine system, including levels of cortisol, ACTH and beta-EP persist throughout the first month of abstinence. These results suggest that neuroendocrine system dysfunctions in heroin abusers is independent of the acute and protracted withdrawal syndromes, and may thus contribute to relapse to heroin use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, heroin craving has been shown to be positively correlated with serum cortisol levels [and negatively correlated with plasma β-endorphin levels (43)], emphasizing the need to target the anti-reward system in the long-term management of OUD.”
From Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice (2019) · cites this paper as [43]
Citations
Cites
How does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505
Molecular and Cellular Basis of Addiction
Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,313 · cited 3×
“Those long-term neurobiological changes after detoxification may be one of the underlying mechanisms of relapse to drug abuse (4, 5).”
BackgroundMethodStress dysregulation of drug reward pathways, and the transition to drug dependence
Koob, & Kreek, M. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05030503 · Cited by 868 · cited 1×
“Drugs of abuse have complex effects on the HPA axis (10, 12), particularly on the hormones involved in this system, such as corticotrophin-releasing factor (CRF), adrenocorticotrophic hormone (ACTH), and cortisol.”
BackgroundDrug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696 · cited 1×
“The following criteria were exclusionary: (1) any of the exclusion criteria for the experimental group; (2) past or present DSM-IV Axis I or Axis II disorders (including alcohol/substance abuse or dependence); (3) sleep disturbance; (4) younger than 18 years of age; (5) use of any medication 7 days prior to the partic…”
MethodPiazza, P. V., & Le Moal, M. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002043 · Cited by 690
Role of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Neurobiology of craving, conditioned reward and relapse
Weiss, F. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.11.001 · Cited by 411 · cited 1×
“Although previous studies suggest that neuroendocrine changes during heroin withdrawal may contribute to clinical symptoms and possibly relapse (24), they did not measure the fluctuations of all these factors at different time points during heroin withdrawal.”
BackgroundSinha, R., Talih, M., Malison, R., Cooney, N., Anderson, G. M., & Kreek, M. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1525-8 · Cited by 366
The Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 351 · cited 2×
“Drugs of abuse have complex effects on the HPA axis (10, 12), particularly on the hormones involved in this system, such as corticotrophin-releasing factor (CRF), adrenocorticotrophic hormone (ACTH), and cortisol.”
BackgroundNeurobiology of Addiction: Toward the Development of New Therapies
KOOB, G. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06682.x · Cited by 317 · cited 3×
“Drug addiction is a chronic relapsing brain disorder characterized by neurobiological changes that lead to a compulsion to take drugs (1).”
BackgroundMethodGoeders, N. E. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.785 · Cited by 286 · cited 2×
“, active tuberculosis, acute hepatitis, or cirrhosis, renal, cardiovascular illness, and unstable diabetes); (6) Psychiatric disorders.”
BackgroundMethodPharmacologic Treatment of Heroin-Dependent Patients
O'Connor, P. G., & Fiellin, D. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00008 · Cited by 183 · cited 3×
“Those long-term neurobiological changes after detoxification may be one of the underlying mechanisms of relapse to drug abuse (4, 5).”
BackgroundMethodLeptin Attenuates Acute Food Deprivation-Induced Relapse to Heroin Seeking
Shalev, U., Yap, J., & Shaham, Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-j0001.2001 · Cited by 183
Neuroendocrine pathways of addictive behaviour
F, K., & K, W. (2004) · Addiction Biology · doi:10.1080/13556210412331292532 · Cited by 107
Glucocorticoids and neuroendocrine function
Cavagnini, F., Croci, M., Putignano, P., Petroni, M. L., & Invitti, C. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801284 · Cited by 105 · cited 1×
“Studies have suggested that feedback loops exist between glucocorticoids, leptin, and NPY when the HPA is activated by stress (36).”
BackgroundRITTMASTER, R. S., CUTLER, G. B., SOBEL, D. O., GOLDSTEIN, D. S., KOPPELMAN, M. C. S., LORIAUX, D. L., & CHROUSOS, G. P. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-5-891 · Cited by 102 · cited 2×
“The RIA Kit was purchased from Furui biotechnology company, Beijing, China.”
MethodKreek, M. J., Wardlaw, S. L., Hartman, N., Raghunath, J., Friedman, J., Schneider, B., & Frantz, A. G. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90529-5 · Cited by 92 · cited 1×
“Plasma levels of ACTH and cortisol are reduced during active heroin exposure and return to normal following methadone treatment (13, 14).”
BackgroundInfluentialDepression and Stimulant Dependence: Neurobiology and Pharmacotherapy
KOSTEN, T. R., MARKOU, A., & KOOB, G. F. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199812000-00001 · Cited by 77
Self-citationShi, J., Zhao, L.-Y., Epstein, D. H., Zhang, X.-L., & Lu, L. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.010 · Cited by 65 · cited 5×
“Following opiate withdrawal, protracted symptoms like craving and mood changes can persist, even after somatic withdrawal symptoms have disappeared (2, 3).”
BackgroundMethodSelf-citationBeta-endorphin-like immunoactivity in the plasma of heroin addicts and normal subjects
Ho, W. K. K., Wen, H. L., & LING, N. C. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90175-6 · Cited by 61 · cited 1×
“Our current study confirmed the similar pattern of their alteration (20, 21, 32, 33), although beta-EP levels began to rise after 10 days of withdrawal.”
ResultHypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts
CAMÍ, J., GILABERT, M., SAN, L., & DE LA TORRE, R. (1992) · British Journal of Addiction · doi:10.1111/j.1360-0443.1992.tb02001.x · Cited by 55 · cited 2×
“The hypercortisolism of heroin-dependent patients during withdrawal in the current study is consistent with the previous findings (15, 26).”
BackgroundResultAdipocyte-derived hormones in heroin addicts: the influence of methadone maintenance treatment
Housová, J., Wilczek, H., Haluzík, M., Křížová, J., & Haluzík, M. (2005) · Physiological Research · doi:10.33549/physiolres.930568 · Cited by 52 · cited 3×
“Some studies showed that decreased leptin levels caused by chronic heroin administration returned to normal after MMT (22); whereas Wilczek et al. found no significant difference in leptin levels between heroin dependent patients and controls, but that leptin levels in heroin dependents decreased after one-year of met…”
BackgroundInfluentialIs withdrawal-induced anxiety in alcoholism based on β-endorphin deficiency?
Kiefer, F., Horntrich, M., Jahn, H., & Wiedemann, K. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1118-y · Cited by 47
Salivary cortisol during opiate dependence and withdrawal
Bearn, J., Buntwal, N., Papadopoulos, A., & Checkley, S. (2001) · Addiction Biology · doi:10.1080/13556210020040235 · Cited by 42 · cited 1×
“In contrast, withdrawal from heroin disrupts the function of the HPA axis (15, 16).”
BackgroundCortisol levels and depression in men and women using heroin and cocaine
Wisniewski, A. B., Brown, T. T., John, M., Cofranceso, J., Golub, E. T., Ricketts, E. P., Wand, G. S., & Dobs, A. S. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.002 · Cited by 35 · cited 1×
“Higher cortisol levels and more depressive episodes have also been found in cocaine users (28).”
BackgroundMetyrapone‐induced withdrawal symptoms
KENNEDY, J. A., HARTMAN, N., SBRIGLIO, R., KHURI, E., & KREEK, M. J. (1990) · British Journal of Addiction · doi:10.1111/j.1360-0443.1990.tb03438.x · Cited by 33
Cohen, L. J., Gertmenian-King, E., Kunik, L., Weaver, C. L., London, E. D., & GALYNKER, I. I. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00546.x · Cited by 33 · cited 5×
“ACTH levels were stable between days 3 and 30 during heroin withdrawal (Table 2; F (3, 40) = .”
BackgroundMethodInfluentialWen, H. L., Ho, W. K. K., LING, N. C., Mehal, Z. D., & Ng, Y.-Y. (1980) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x80000104 · Cited by 30 · cited 1×
“Our current study confirmed the similar pattern of their alteration (20, 21, 32, 33), although beta-EP levels began to rise after 10 days of withdrawal.”
ResultMethadone-maintained patients. Effect of methadone on plasma testosterone, FSH, LH, and prolactin.
Cushman, P., & Mj, K. (1974) · PubMed · Cited by 29
Comparison of the effectiveness of different opioid peptides in suppressing heroin withdrawal
Wen, H. L., Ho, W. K. K., & Wen, P. Y. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90217-6 · Cited by 28 · cited 1×
“Previous studies have shown that lack of endogenous opioids contributed to acute withdrawal symptoms, especially the somatic withdrawal symptoms (34, 35) and that acupuncture could provide relief by producing an increase in the beta-EP levels in cerebrospinal fluid.”
BackgroundGerra, G., Ceresini, S., Esposito, A., Zaimovic, A., Moi, G., Bussandri, M., Raggi, M. A., & Molina, E. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200309000-00002 · Cited by 25 · cited 4×
“For example, elevation of ACTH levels in heroin dependent patients was found following rapid opioid detoxification with naloxone (26) or after acupuncture and electrical stimulation together with limited doses of naloxone (29).”
BackgroundResultInfluentialEndogenous opioids in cerebrospinal fluid of opioid-dependent humans
O’Brien, C. P., Terenius, L. Y., Nyberg, F., McLellan, A. T., & Eriksson, I. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90139-4 · Cited by 24 · cited 1×
“Our current study confirmed the similar pattern of their alteration (20, 21, 32, 33), although beta-EP levels began to rise after 10 days of withdrawal.”
ResultClausen, T. R., Møller, M., & Woldbye, D. P. D. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1092 · Cited by 24 · cited 1×
“Indeed, it has been demonstrated that disrupted leptin and NPY secretion is involved in the somatic withdrawal symptoms experienced by heroin addicts (37, 38).”
BackgroundVescovi, P. P., Gerra, G., Maninetti, L., Pedrazzoni, M., Michelini, M., Pioli, G., Girasole, G., Caccavari, R., Maestri, D., & Passeri, M. (1990) · Neuropeptides · doi:10.1016/0143-4179(90)90143-m · Cited by 16 · cited 1×
“However, ACTH levels were decreased in heroin addicts, as compared to control subjects, after six-month methadone maintenance treatment (30).”
BackgroundWen, H. L., Ho, W. K. K., WONG, H. K., Mehal, Z. D., Ng, Y.-Y., & Ma, L. (1978) · The American Journal of Chinese Medicine · doi:10.1142/s0147291778000319 · Cited by 14 · cited 2×
“For example, elevation of ACTH levels in heroin dependent patients was found following rapid opioid detoxification with naloxone (26) or after acupuncture and electrical stimulation together with limited doses of naloxone (29).”
BackgroundResultEnhancement of 3H-phenytoin binding by diazepam and (+) bicuculline
Okazaki, M. M., Madras, B. K., Livingston, K. E., Spero, L., & Burnham, W. M. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90788-9 · Cited by 12
Lack of neuropeptide Y attenuates the somatic signs of opiate withdrawal
Olson, V. G., Griner, N. B., Heusner, C. L., & Palmiter, R. D. (2006) · Synapse · doi:10.1002/syn.20328 · Cited by 8 · cited 1×
“Indeed, it has been demonstrated that disrupted leptin and NPY secretion is involved in the somatic withdrawal symptoms experienced by heroin addicts (37, 38).”
BackgroundSuppression of morphine abstinence in heroin addicts by beta-endorphin.
Su, C. Y., Cs, L., Peng, C., Cs, C., Hh, L., Ch, L., & Way, E. L. (1980) · PubMed · Cited by 8
Gil‐Ad, I., Bar-Yoseph, J., Smadja, Y., Zohar, M., & Laron, Z. (1985) · PubMed · Cited by 7
Wilczek, H., Haluzík, M., Svobodová, J., & Pařízková, J. (2004) · PubMed · Cited by 6
Research works printed but not linked: 6
- Cushman P, 1974, N Y State J Med, 74, 1970
- Kiefer F, 2004, Addict Biol, 9, 205, 10.1111/j.1369-1600.2004.tb00534.x · doi:10.1111/j.1369-1600.2004.tb00534.x · Paper page
- Gil-Ad I, 1985, Isr J Med Sci, 21, 601
- Wilczek H, 2004, Vnitr Lek, 50, 282
- Wen H L, 1979, Comp Med East West, 6, 241
- Su C Y, 1980, Adv Biochem Psychopharmacol, 22, 503
Cited by
Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions
Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 576
Pergolizzi, J. V., Raffa, R. B., & Rosenblatt, M. H. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13114 · Cited by 229
Modeling withdrawal syndrome in zebrafish
Cachat, J., Canavello, P., Elegante, M., Bartels, B., Hart, P., Bergner, C., Egan, R., Duncan, A., Tien, D., Chung, A., et al. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.004 · Cited by 189
Zebrafish models to study drug abuse-related phenotypes
Stewart, A., Wong, K., Cachat, J., Gaikwad, S., Kyzar, E. J., Wu, N., Hart, P. C., Piet, V., Utterback, E., Elegante, M. F., et al. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.011 · Cited by 158
“Potentially interesting directions of research could focus on neurochemical alterations, neural circuits, and the long-term consequences (Nava et al. , 2006 ; Li et al. , 2008 ; Zhang et al. , 2008 ; Shi et al. , 2009 ) of drug withdrawal in zebrafi sh.”
BackgroundResultDrug-induced stress responses and addiction risk and relapse
Wemm, S. E., & Sinha, R. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100148 · Cited by 144
Metadata
- Authors
- Shi, J., Li, S.-X., Zhang, X.-L., Wang, X., Foll, B. L., Zhang, X.-Y., Kosten, T. R., & Lu, L.
- Affiliations
- Peking University (CN)
- Baylor College of Medicine (US)
- Centre for Addiction and Mental Health (CA)
- Venue
- The American Journal of Drug and Alcohol Abuse
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 35
- Issue
- 5
- Pages
- 267-272
- ISSN
- 0095-2990 (ISSN-L)
- 1097-9891
- OpenAlex
- W2137847958
- Cited by
- 52
- References
- 40
- Citations by year
- 2025: 6 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 6 · 2013: 1 · 2012: 2
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Drug and Alcohol Abuse (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Key Research and Development Program of China
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- heroin addiction, heroin withdrawal, abstinence, drug craving, neuroendocrine system, cortisol, ACTH, beta-endorphin, leptin, neuropeptide Y, anxiety, depression, relapse
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Analysis of Variance, Anxiety, beta-Endorphin, Depression, Heroin, Heroin Dependence, Humans, Hydrocortisone, Male, Neuropeptide Y, Neurosecretory Systems, Psychiatric Status Rating Scales, Radioimmunoassay, Substance Withdrawal Syndrome, Time Factors, Case-Control Studies, Patient Selection, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.